TELA Bio (TELA) Return on Capital Employed (2019 - 2026)
TELA Bio (TELA) posted quarterly Return on Capital Employed of 58.47% for Q1 2026, up 235.0% year-over-year from 17.45% in Q1 2025, and up 7.28% quarter-over-quarter from 63.06% in Q4 2025.
TELA Bio (TELA) Return on Capital Employed (2019 - 2026) Analysis & Trends
TELA Bio's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 58.47% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 235.0% year-over-year to 58.47%; the TTM figure through Mar 2026 stood at 58.47% (up 235.0% YoY), while the FY2025 annual figure was 51.13%, up 1.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 58.47%, up from 63.06% in the prior quarter.
- The five-year high for Return on Capital Employed was 54.6% in Q3 2023, with the low at 95.69% in Q3 2024.
- The 5-year median for Return on Capital Employed is 67.07% (2023), against an average of 69.61%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed sank 4339 bps in 2022, then surged 2117 bps in 2025.
- TELA Bio's Return on Capital Employed stood at 63.63% in 2022, then retreated by 5 bps to 67.07% in 2023, then increased by 6 bps to 62.95% in 2024, then decreased by 0 bps to 63.06% in 2025, then gained by 7 bps to 58.47% in 2026.
- Business Quant data shows TELA's Return on Capital Employed at 58.47% in Q1 2026, 63.06% in Q4 2025, and 74.52% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 12.08% |
| 10 | TELA Bio | 37.86 Mn | 7.44 Mn | 13.94 Mn | -72.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -72.99% |
| Mar 31, 2026 | -58.47% |
| Dec 31, 2025 | -63.06% |
| Sep 30, 2025 | -74.52% |
| Jun 30, 2025 | -69.89% |
| Mar 31, 2025 | -60.82% |
| Dec 31, 2024 | -62.95% |
| Sep 30, 2024 | -95.69% |
| Jun 30, 2024 | -76.14% |
| Mar 31, 2024 | -62.99% |
| Dec 31, 2023 | -67.07% |
| Sep 30, 2023 | -54.60% |
| Jun 30, 2023 | -63.80% |
| Mar 31, 2023 | -82.63% |
| Dec 31, 2022 | -63.63% |
| Sep 30, 2022 | -74.10% |
| Jun 30, 2022 | -84.39% |
| Mar 31, 2022 | -68.63% |
| Dec 31, 2021 | -53.45% |
| Sep 30, 2021 | -46.09% |